Patrice Chevallier

68PUBLICATIONS
227CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyTransplantation immunologyMedical infection agents (incl. prions)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jun 22, 2026
Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

|May 04, 2026
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study.

|Apr 16, 2026
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.

|Apr 13, 2026
Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC.

Aude-Marie Fourmont, David Beauvais, Marie Balsat

|Dec 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster

|Oct 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Patryk Sobieralski, Tomasz Czerw, Luuk Gras

Pageof 12

Frequent Collaborators

14 joint publications

Edouard Forcade

13 joint publications

Ibrahim Yakoub-Agha

11 joint publications

Thierry Guillaume

11 joint publications

Didier Blaise